Clinical response to omalizumab in patients with hereditary α-tryptasemia.

ABSTRACT:

SUBMITTER: Mendoza Alvarez LB 

PROVIDER: S-EPMC11854589 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature